1. Lessons from 60 years of pharmaceutical innovation;Munos;Nature Reviews. Drug Discovery,2009
2. Holdren , J.P. Lander , E. Press , W. Savitz , M. Blerbaum , R. Gates , J.S. , Jr. Cassel , C. Gorenberg , M. Jackson , S.A. Chyba , C. Levin , R.C. Mirkin , C. Schaal , B. Schmidt , E. Molina , M. Schrag , D. Shaw , D.E. Moniz , E.J. Zewall , A. Mundle , C. Penhoet , E. 2012 Report to the President on “propelling innovation in drug discovery, development and evaluation” http://www.whitehouse.gov/sites/default/files/microsites/ostp/pcast-fda-final.pdf
3. Clinical development success rates for investigational drugs;Hay;Nature Biotechnology,2014
4. Managing the drug discovery/development interface;Kennedy;Drug Discovery and Development,1997
5. Timing of new black box warnings and withdrawals for prescription medications;Lasser;The Journal of the American Medical Association,2002